nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—CCR1—Chemokine receptors bind chemokines—CXCL11—nasal cavity cancer	0.41	0.41	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—CXCL11—nasal cavity cancer	0.154	0.154	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.13	0.13	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.104	0.104	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0788	0.0788	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.0446	0.0446	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0405	0.0405	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL11—nasal cavity cancer	0.0239	0.0239	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—FRS2—nasal cavity cancer	0.0141	0.0141	CbGpPWpGaD
